SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 99 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $35,757,583 | +77.3% | 9,459,678 | +214.3% | 0.70% | +84.8% |
Q2 2023 | $20,164,843 | +2.9% | 3,009,678 | 0.0% | 0.38% | -14.2% |
Q1 2023 | $19,593,004 | -23.7% | 3,009,678 | 0.0% | 0.44% | -14.8% |
Q4 2022 | $25,672,553 | +121.3% | 3,009,678 | +72.8% | 0.52% | +154.1% |
Q4 2021 | $11,603,000 | -33.3% | 1,742,186 | 0.0% | 0.20% | -14.9% |
Q3 2021 | $17,387,000 | -67.7% | 1,742,186 | 0.0% | 0.24% | -72.1% |
Q2 2021 | $53,816,000 | -29.2% | 1,742,186 | 0.0% | 0.86% | -24.6% |
Q1 2021 | $76,012,000 | -5.8% | 1,742,186 | 0.0% | 1.15% | +1.5% |
Q4 2020 | $80,733,000 | – | 1,742,186 | – | 1.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,618,036 | $80,871,000 | 3.02% |
Orbimed Advisors | 8,740,887 | $270,006,000 | 2.73% |
Boxer Capital, LLC | 1,675,377 | $51,752,000 | 1.83% |
Endurant Capital Management LP | 139,124 | $4,298,000 | 1.18% |
Nantahala Capital Management | 1,266,266 | $39,115,000 | 1.11% |
COMMODORE CAPITAL LP | 97,143 | $3,001,000 | 1.05% |
Ally Bridge Group (NY) LLC | 128,572 | $3,972,000 | 0.99% |
RA Capital Management | 1,742,186 | $53,816,000 | 0.86% |
HighVista Strategies LLC | 25,906 | $800,000 | 0.57% |
SPHERA FUNDS MANAGEMENT LTD. | 173,891 | $5,371,000 | 0.36% |